Fukase, Yuko
Kamide, Naoto
Sakamoto, Miki
Ando, Masataka
Ichikura, Kanako
Shiba, Yoshitaka
Tagaya, Hirokuni
Funding for this research was provided by:
Japan Society for the Promotion of Science (20H01771, 19K11394, 20K07952)
Article History
Received: 25 April 2023
Accepted: 8 May 2024
First Online: 24 May 2024
Declarations
:
: The Research Ethics Review Committee of Kitasato University School of Allied Health Sciences approved this study (approval numbers was 2018-008B). All participants were informed of the purposes of the present study and their right to quit the survey before they participated and written informed consent was obtained from all participants in the study. This study was conducted in accordance with the 1964 Helsinki Declaration and its later amendments.
: Not applicable.
: YF received research grants from the Murata Science Foundation. KI was an advisor for private health care services under Clinical Study Support, Inc. HT served as a scientific advisor for Taisho Pharmaceutical Co., Ltd., and received personal fees from Eisai Co. Ltd., Daiichi Sankyo Co. Ltd. and MSD Co. Ltd., outside the submitted work. The other authors have no conflicts of interest to declare.